UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 7 von 7305391
Datensatz exportieren als...
BibTeX
Antiviral drug resistance in herpesviruses other than cytomegalovirus
Reviews in medical virology, 2014-05, Vol.24 (3), p.186-218
Piret, Jocelyne
Boivin, Guy
2014
Details
Autor(en) / Beteiligte
Piret, Jocelyne
Boivin, Guy
Titel
Antiviral drug resistance in herpesviruses other than cytomegalovirus
Ist Teil von
Reviews in medical virology, 2014-05, Vol.24 (3), p.186-218
Ort / Verlag
England: Blackwell Publishing Ltd
Erscheinungsjahr
2014
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
SUMMARY The discovery of acyclovir (ACV), a nucleoside analogue, more than 30 years ago, represents a milestone in the management of HSV and VZV infections. The modest activity of ACV against CMV prompted the development of another nucleoside analogue, ganciclovir, for the management of systemic and organ‐specific CMV diseases. Second‐line agents such as the pyrophosphate analogue foscarnet and the nucleotide analogue cidofovir have been approved subsequently. In contrast to ACV and ganciclovir, the latter drugs do not require selective phosphorylation by viral protein kinases to be converted into their active forms. Since the introduction of these antivirals, the emergence of drug‐resistant mutants has been constantly reported particularly in severely immunocompromised patients such as bone marrow and solid organ transplant recipients as well as HIV‐infected individuals. In this manuscript, we discuss the characteristics of the antiviral agents currently approved for the management of HSV, VZV and CMV diseases. In recent years, the resistance of CMV to antiviral drugs has been extensively reviewed. The emergence of antiviral drug resistance is also observed with other members of the Herpesviridae family, namely HSV‐1, HSV‐2, VZV and HHV‐6, which are the focus of this review. More specifically, we describe the laboratory methods for assessing drug susceptibilities, the frequency and clinical significance of drug‐resistant infections and their management. Copyright © 2014 John Wiley & Sons, Ltd.
Sprache
Englisch
Identifikatoren
ISSN: 1052-9276
eISSN: 1099-1654
DOI: 10.1002/rmv.1787
Titel-ID: cdi_proquest_miscellaneous_1664214650
Format
–
Schlagworte
Acyclovir - therapeutic use
,
Antiviral Agents - therapeutic use
,
Cytomegalovirus
,
Cytomegalovirus - drug effects
,
Cytomegalovirus - genetics
,
Cytomegalovirus - metabolism
,
Cytosine - analogs & derivatives
,
Cytosine - therapeutic use
,
Drug Resistance, Viral - genetics
,
Foscarnet - therapeutic use
,
Ganciclovir - therapeutic use
,
Herpes simplex virus 1
,
Herpesviridae
,
Herpesviridae Infections - drug therapy
,
Herpesviridae Infections - immunology
,
Herpesviridae Infections - virology
,
Herpesvirus 1, Human - drug effects
,
Herpesvirus 1, Human - genetics
,
Herpesvirus 1, Human - metabolism
,
Herpesvirus 2, Human - drug effects
,
Herpesvirus 2, Human - genetics
,
Herpesvirus 2, Human - metabolism
,
Herpesvirus 3, Human - drug effects
,
Herpesvirus 3, Human - genetics
,
Herpesvirus 3, Human - metabolism
,
Herpesvirus 6, Human - drug effects
,
Herpesvirus 6, Human - genetics
,
Herpesvirus 6, Human - metabolism
,
Human herpesvirus 6
,
Human immunodeficiency virus
,
Humans
,
Immunocompromised Host
,
Organophosphonates - therapeutic use
,
Varicella-zoster virus
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX